Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, ...
Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on factors such as disease severity, ...
Panelists discuss how adverse events associated with conventional therapies for alopecia areata (AA) are monitored through regular patient assessments, and how these events are managed by adjusting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results